基于 4 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the detailed record of transactions filed by Robert W. Shaw, 董事. Director active across 1 company, notably Ultralife CORP. In total, 5 filings have been recorded. Split: 5 buys · 0 sell. Total volume traded: €80k. History available since 7 February 2022. The latest transaction was disclosed on 24 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Robert W. Shaw serves as a Director at ULTRALIFE CORP. He brings his expertise in corporate governance and strategy. His role as a director includes participating in board meetings and contributing to strategic decision-making for the company.